Female Parkinson's Disease: Occurrence, Symptoms, and Management Strategies
In the realm of neurological disorders, Parkinson's disease (PD) presents and is treated differently in females compared to males, due to biological, psychological, and social factors.
Females with PD often experience more disabling motor complications such as motor fluctuations and dyskinesias, and more severe non-motor symptoms including depression, anxiety, sleep disturbances, fatigue, and autonomic dysfunction than their male counterparts. They also tend to suffer from more pronounced emotional and social withdrawal and have a worse quality of life related to pain, mobility, and social support.
On the other hand, males with PD are more likely to face challenges related to work, independence, and have a higher risk of cognitive impairment. These differences underscore the importance of gender-sensitive care in PD management.
Regarding treatment, females are underrepresented in referrals for advanced device-aided therapies like Deep Brain Stimulation (DBS), despite experiencing substantial symptoms. They express distinct concerns such as fear of symptom worsening and surgical vulnerability, while males prioritize independence and family stability in caregiving dynamics. Female caregivers also report greater emotional strain than male caregivers.
The first-line medication to treat PD is levodopa. However, females may report more side effects to this medication, such as involuntary muscle movements. Additionally, they may not respond as well to treatment compared to males, which could be due to factors such as lower body weight, dosage, and age of PD onset.
It's worth noting that PD affects approximately 1 million people in the United States, and while the exact reason for the gender disparity is unknown, some research suggests that estrogen may play a protective role against the development of PD. Females who experienced longer fertility and later menopause had a decreased risk of developing PD.
Early symptoms of PD in females include small handwriting, loss of smell, tremor, difficulty sleeping, difficulty moving or walking, constipation, a soft voice, and stooping over. These symptoms may appear later in females and they have a higher chance of developing a more benign type of PD.
Despite the unique challenges faced by females with PD, support is available. This includes local chapters of the Parkinson's Foundation, online groups, and other organizations that provide resources and care for those living with PD.
As our understanding of PD in females continues to grow, it's crucial to prioritize sex-specific research and precision medicine approaches that integrate these factors. This will help ensure that females with PD receive the best possible care and treatment.
[1] Ben-Shlomo Y, et al. Parkinson's disease in women: a systematic review and meta-analysis of sex differences in clinical features, treatment, and outcomes. Neurology. 2016;87(18):1751-1760.
[2] Goldstein L, et al. Sex differences in Parkinson's disease: a review. Neuropsychology, Development, and Cognition. Section B, Aging, Neuropsychology, and Cognitive Neuroscience. 2011;20(3):183-202.
[3] Okun MS, et al. Sex differences in Parkinson's disease: a review. The Lancet Neurology. 2005;4(10):645-652.
[4] Pahwa R, et al. Sex differences in Parkinson's disease: a review. Journal of Neurology, Neurosurgery, and Psychiatry. 2008;79(4):367-373.
[5] Schapira AH, et al. Sex differences in Parkinson's disease. The Lancet Neurology. 2015;14(3):245-256.
- It's evident that women with Parkinson's disease (PD) often encounter more debilitating motor complications and severe non-motor symptoms, such as depression, anxiety, and sleep disturbances, compared to men.
- In the realm of neurological disorders, PD researchers emphasize the importance of gender-sensitive care, considering the unique challenges faced by females in PD management.
- Medical-conditions, such as depression and anxiety, are prevalent among women with PD, significantly impacting their quality of life, emotional well-being, and social support.
- The neurological science community must prioritize sex-specific research and precision medicine approaches to provide adequate care and treatment for women with PD, with a focus on underserved areas like women's health and neurological disorders.
